Time New York: Wed 13 Dec 08:05 am  |  Save 15% on H&R Block Online

  
caticonslite_bm_alt

Why Koninklijke Ahold Delhaize (ADRNY) Could Be a Top Value Stock Pick

Zacks

Value investing is always a very popular strategy, and for good reason. After all, who doesn’t want to find stocks that have low PEs, solid outlooks, and decent dividends?

Fortunately for investors looking for this combination, we have identified a strong candidate which may be an impressive value; Koninklijke Ahold Delhaize N.V. ADRNY.

Koninklijke Ahold Delhaize in Focus

ADRNY may be an interesting play thanks to its forward PE of 12.9, its P/S ratio of 0.41, and its decent dividend yield of 2.69%. These factors suggest that Koninklijke Ahold Delhaize is a pretty good value pick, as investors have to pay a relatively low level for each dollar of earnings, and that ADRNY has decent revenue metrics to back up its earnings.

Ahold NV PE Ratio (TTM)

Ahold NV PE Ratio (TTM) | Ahold NV Quote


But before you think that Koninklijke Ahold Delhaize is just a pure value play, it is important to note that it has been seeing solid activity on the earnings estimate front as well. For current year earnings, the consensus has gone up by 2.8% in the past 30 days, thanks to one upward revision in the past one month compared to none lower.

This estimate strength is actually enough to push ADRNY to a Zacks Rank #2 (Buy), suggesting it is poised to outperform. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

So really, Koninklijke Ahold Delhaize is looking great from a number of angles thanks to its PE below 20, a P/S ratio below one, and a strong Zacks Rank, meaning that this company could be a great choice for value investors at this time.

More Stock News: 8 Companies Verge on Apple-Like Run

Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2017 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs.

A bonus Zacks Special Report names this breakthrough and the 8 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains. Click to see them right now >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.
<-- You can share this post with your network,
or give us your opinion and leave a comment.
Be sure to check our RSS feeds for updates.